Cardiotoxicity as important differential diagnosis for reduced myocardial blood flow during Rubidium cardiac PET/CT
The International Journal of Cardiovascular Imaging · 2025
DOI: 10.1007/s10554-024-03315-4 ↗Kurz gefasst
Fallbericht in der Zeitschrift The International Journal of Cardiovascular Imaging, 2025. Verfasst von Sabin G Pop und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Cantonal Hospital Baden, Partner Hospital for Research and Teaching of the Medical Faculty of the University of Zuric…. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Rubidium Radioisotopes, Radiopharmaceuticals, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Tübingen.
Abstract (Originalsprache)
A 65-year-old woman with a history of ductal mammary carcinoma and recent autonomic dysfunction underwent a Rb-82 chloride (RbCl) cardiac PET/CT scan that showed no ischemia or scarring, but significantly reduced myocardial flow reserve (MFR) (global: 1.5) and a CAC-Score of 0. The patient’s chemotherapy history (paclitaxel, carboplatin, epirubicin, pembrolizumab 2 years before) with elevated Troponin T and NT-pro-BNP levels at that time, and now reduced MFR with 0 CAC suggests cancer-therapy-related cardiotoxicity. An important differential diagnosis to the more common CAD-associated microvascular disease. Furthermore, tumor recurrence with a PET-avid lymph node metastasis was found additionally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Cantonal Hospital Baden, Partner Hospital for Research and Teaching of the Medical Faculty of the University of Zurich, Baden, 5404, Switzerland.
- Department of Cardiology, Cantonal Hospital Baden, Partner Hospital for Research and Teaching of the Medical Faculty of the University of Zurich, Baden, 5404, Switzerland.
- Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, 8006 , Switzerland.
- Department of Nuclear Medicine, Cantonal Hospital Baden, Partner Hospital for Research and Teaching of the Medical Faculty of the University of Zurich, Baden, 5404, Switzerland. alexanderw.sauter@ksb.ch.
- Department of Radiology, University Hospital Tuebingen, Tuebingen, 72076, Germany. alexanderw.sauter@ksb.ch.
Förderung
- Universitätsklinikum Tübingen
Zitieren
APA
Pop, S. G., Hägler, E., Popescu, C., Burger, I. A., & Sauter, A. W. (2025). Cardiotoxicity as important differential diagnosis for reduced myocardial blood flow during Rubidium cardiac PET/CT. The International Journal of Cardiovascular Imaging. https://doi.org/10.1007/s10554-024-03315-4
Vancouver
Pop SG, Hägler E, Popescu C, Burger IA, Sauter AW. Cardiotoxicity as important differential diagnosis for reduced myocardial blood flow during Rubidium cardiac PET/CT. The International Journal of Cardiovascular Imaging. 2025. doi:10.1007/s10554-024-03315-4
BibTeX
@article{Pop2025,
author = {Pop, Sabin G and Hägler, Eva and Popescu, Cristina and Burger, Irene A and Sauter, Alexander W},
title = {Cardiotoxicity as important differential diagnosis for reduced myocardial blood flow during Rubidium cardiac PET/CT},
journal = {The International Journal of Cardiovascular Imaging},
year = {2025},
doi = {10.1007/s10554-024-03315-4}
}
EUVIMED